In IBD, activated NF-κB upregulated MLCK expression/phosphorylation and subsequently increased the delocalization of tight junction proteins, including ZO-1 and claudin, from the membrane of intestinal epithelial cells, thereby leading to intestinal barrier permeability (Konig et al., 2016). The gene discussed is MYLK; the disease is irritable bowel syndrome.